Abstract
Nearly 300 Americans die every day from unintentional drug overdoses, most involving opioids. Buprenorphine is an effective but underused treatment for opioid use disorder. This quantitative, descriptive study used data from a national survey to explore nurse practitioner buprenorphine prescribing. The study finds associations between full practice authority environments and buprenorphine prescribing propensity. The study also finds stigma and medication misconceptions may inhibit prescribing. To increase access to this lifesaving medication, policymakers, patient advocates, educators, and clinicians should focus on reducing state scope of practice barriers while advocating for education to address stigma and medication misperceptions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.